Vulnerability Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
CVSS Score
6.8
MEDIUM
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Clinical Collaboration Platform | <= 12.2.1 |
Related Weaknesses (CWE)
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party AdvisoryUS Government Resource
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.h
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2020-16247?
CVE-2020-16247 is a vulnerability with a CVSS score of 6.8 (MEDIUM). Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
How severe is CVE-2020-16247?
CVE-2020-16247 has been rated MEDIUM with a CVSS base score of 6.8/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2020-16247?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Clinical Collaboration Platform.